New Director's Experience a Plus for MSU, but his Controversial Views Concern Some
By Matthew Miller,
Lansing State Journal
| 10. 06. 2012
Stephen Hsu was an unconventional choice to lead Michigan State University’s research enterprise.
A theoretical physicist by training, Hsu has done respected work on dark energy, black holes and the more esoteric reaches of particle physics, but his only experience in academic administration was a stint last year as the director of the University of Oregon’s Institute for Theoretical Science. The institute’s budget that year was just shy of $74,000.
As vice president for research and graduate studies at MSU, the position he assumed in August, Hsu is charged with setting the broad direction and expectations for a research operation that topped $400 million in expenditures in 2010. His office administers millions in internal grant money, ensures the university’s compliance with ethical and legal standards for research, leads MSU’s efforts to commercialize its research.
But Hsu has another sort of experience that MSU’s leaders found compelling: years as a Silicon Valley entrepreneur, and a successful one at that.
MSU President Lou Anna Simon said Hsu is not only “an extraordinary intellect,” but he “understands the relationship of research to economic... see more
"Human Egg" by euthman is licensed under CC BY 2.0.
In late April, the National Academies held a three-day workshop on In Vitro Derived Human Gametes as a Reproductive Technology
. Experts from a broad range of fields commented on the fast-developing science, its potential applications in assisted reproduction, and its social implications. Despite a focus on the significant technical challenges that remain in developing these techniques and the notable inclusion of several critical voices, the overall...
By CGS Staff
On May 4, the Center for Genetics and Society contributed invited remarks about heritable gene editing at a comment session hosted by the National Council on Disability (NCD), the US federal agency that advises government and the private sector on disability policy. Some 17 speakers, including representatives of disability and patient advocacy organizations, scholars, medical researchers, and genetic counselors, weighed in for three minutes each on the topic “Germline editing, fetal medicine, and their impact on people with disabilities.”
By Ian Sample, The Guardian | 05.09.2023
The first UK baby created with DNA from three people has been born after doctors performed a groundbreaking IVF procedure that aims to prevent children from inheriting incurable diseases.
The technique, known as mitochondrial donation treatment (MDT), uses tissue from...
By Antonio Regalado, MIT Technology Review | 04.26.2023
Elizabeth Carr is head of commercial development at Genomic Prediction, a New Jersey genetic testing startup that says it will assess embryos created in IVF clinics for their future chance of common diseases and then rank them, so parents...